GCNT2

protein-coding

glucosaminyl (N-acetyl) transferase 2 (I blood group), the group of Glucosaminyl (N-acetyl) transferases/xylosyltransferases|Blood group antigens

Gene summary

This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Previous symbols:
  • NACGT1
  • II
  • GCNT5
  • CCAT

MANE transcript

NM_145649.5

Inheritance

AR, AD, BG

ClinVar variants

P:13U:28B:11

Top phenotype

Blood group, Ii; Adult i phenotype without cataract

gnomAD constraint

pLI —, LoF o/e 0.67

Max pathogenic AF

—

Genomic locus

chr6:10,492,223-10,629,368

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~137.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

cataract 13 with adult I phenotypeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0007289

Submitter: Ambry Genetics

cataract 13 with adult I phenotypeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0007289

Submitter: PanelApp Australia

total early-onset cataractSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0021548

Submitter: Orphanet

cataract 13 with adult I phenotypeDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0007289

Submitter: G2P

cataract 13 with adult I phenotypeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0007289

Submitter: Labcorp Genetics (formerly Invitae)

cataract 13 with adult I phenotypeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0007289

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Blood group, Ii; Adult i phenotype without cataractBG/AR

Manifestation: Hematologic; Ophthalmologic

Intervention: Hematologic

Rationale: Variants associated with a blood group may be important in specific situations (eg, related to transfusion)

Refs: 6858080; 3799539; 11739194; 12424189; 21912254Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to GCNT2 variants in ClinVar

9 Conditions Cataloged
Cataract 13 with adult I phenotypeTotal: 39
Blood group, I systemTotal: 34
not providedTotal: 31
GCNT2-related disorderTotal: 30
Inborn genetic diseasesTotal: 20
not specifiedTotal: 6
Developmental cataractTotal: 2
ADULT i BLOOD GROUP PHENOTYPETotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_145649.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
5
clinvar
7
missense
4
clinvar
4
clinvar
24
clinvar
6
clinvar
38
nonsense
1
clinvar
2
clinvar
1
clinvar
4
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total582811052

Highest pathogenic variant AF is 0.00016058072

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 31 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_145649.5RefSeqNP_663624.13MANE Select
ENST00000495262.7EnsemblENSP00000419411.23MANE Select
NM_001374747.1RefSeqNP_001361676.13Standard
NM_001491.3RefSeqNP_001482.13MANE Plus Clinical

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human)
  • Glycosphingolipid biosynthesis - neolactoseries
  • terminal <i>O</i>-glycans residues modification

Biological Process

  • glycosaminoglycan biosynthetic process
  • protein glycosylation
  • transforming growth factor beta receptor signaling pathway
  • multicellular organism development
  • positive regulation of cell population proliferation

Molecular Function

  • N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity

Cellular Component

  • Golgi membrane
  • cellular_component
  • Golgi apparatus
  • membrane
  • integral component of membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000379597
Coding exons
3
Length
137146
Individuals with no LoFs
125589
Homozygous LoFs
0
Heterozygous LoFs
159
Defined
125748
p
0.000632
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-1.102622161.210.00001202643
Missense (PolyPhen)7264.9811.108830
Synonymous-1.2810589.61.170.00000578783
Loss of Function1.14913.50.6656.53e-7168

Population LoF Frequency

PopulationCAFp-valueStatus
African0.00170.0017notable
Latino/Admixed American0.000290.00029rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.00260.0026notable
Finnish0.000280.00028rare
European (Non-Finnish)0.000250.00025rare
South Asian0.00100.0010notable
Other0.000980.00098rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. {ECO:0000269|PubMed:7579796, ECO:0000269|PubMed:8449405}.;
Disease
DISEASE: Cataract 13, with adult i phenotype (CTRCT13) [MIM:116700]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT13 is associated with the rare adult i phenotype, in which adult red blood cells are rich in i antigen and contain low levels of I antigen. {ECO:0000269|PubMed:11739194}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.159

Intolerance Scores

LoFtool
0.977
RVIS EVS
-1.3
RVIS percentile EVS
4.95

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.414

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.